![conference banner](/images/conference-banner.jpeg)
Abstract
Type 1 diabetes mellitus (T1DM) is a T cell-mediated autoimmune disease resulting in islet β cell destruction, hypoinsulinemia, and severely altered glucose homeostasis. T1DM has classically been attributed to the pathogenic actions of auto-reactive effector T cells(Teffs) on the β cell. Recent literature now suggests that a failure of a second T cell subtype, known as regulatory T cells (Tregs), plays a critical role in the development of T1DM. During immune homeostasis, Tregs counterbalance the actions of autoreactive Teff cells, thereby participating in peripheral tolerance. An imbalance in the activity between Teff and Tregs may be crucial in the breakdown of peripheral tolerance, leading to the development of T1DM. In this review, we summarize our current understanding of Treg function in health and in T1DM, and examine the effect of experimental therapies for T1DM on Treg cell number and function in both mice and humans.
Keywords: Autoimmunity, effector T cells, regulatory T cells, Teffs, Tregs, Type 1 diabetes mellitus, autoimmune disease, hyperglycemic, phenotype, antigens, autoantigens, viral infection, cytokines, insulitis, chemokines
Current Molecular Medicine
Title:Targeting Regulatory T Cells in the Treatment of Type 1 Diabetes Mellitus
Volume: 12 Issue: 10
Author(s): S.M. Cabrera, M.R. Rigby and R.G. Mirmira
Affiliation:
Keywords: Autoimmunity, effector T cells, regulatory T cells, Teffs, Tregs, Type 1 diabetes mellitus, autoimmune disease, hyperglycemic, phenotype, antigens, autoantigens, viral infection, cytokines, insulitis, chemokines
Abstract: Type 1 diabetes mellitus (T1DM) is a T cell-mediated autoimmune disease resulting in islet β cell destruction, hypoinsulinemia, and severely altered glucose homeostasis. T1DM has classically been attributed to the pathogenic actions of auto-reactive effector T cells(Teffs) on the β cell. Recent literature now suggests that a failure of a second T cell subtype, known as regulatory T cells (Tregs), plays a critical role in the development of T1DM. During immune homeostasis, Tregs counterbalance the actions of autoreactive Teff cells, thereby participating in peripheral tolerance. An imbalance in the activity between Teff and Tregs may be crucial in the breakdown of peripheral tolerance, leading to the development of T1DM. In this review, we summarize our current understanding of Treg function in health and in T1DM, and examine the effect of experimental therapies for T1DM on Treg cell number and function in both mice and humans.
Export Options
About this article
Cite this article as:
Cabrera S.M., Rigby M.R. and Mirmira R.G., Targeting Regulatory T Cells in the Treatment of Type 1 Diabetes Mellitus, Current Molecular Medicine 2012; 12 (10) . https://dx.doi.org/10.2174/156652412803833634
DOI https://dx.doi.org/10.2174/156652412803833634 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Metformin Beyond Diabetes: New Life for an Old Drug
Current Diabetes Reviews Purinergic (P2) Receptor Control of Lower Genitourinary Tract Function and New Avenues for Drug Action: An Overview
Current Pharmaceutical Design Periodontal Regenerative Materials and Their Applications: Goodness of Fit?
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Incretins and Preservation of Endothelial Function
Cardiovascular & Hematological Agents in Medicinal Chemistry Disorder in Milk Proteins: α -Lactalbumin. Part A. Structural Properties and Conformational Behavior
Current Protein & Peptide Science Modulation of Platelet Function and Signaling by Flavonoids
Mini-Reviews in Medicinal Chemistry Heart Failure and Diabetes: Perspective of a Dangerous Association
Current Hypertension Reviews Clinical Pharmacology of Frequently Used Intravenous Drugs During Bariatric Surgery in Adolescents
Current Pharmaceutical Design Antihyperglycemic and Antidyslipidemic Activities of the <i>Aqueous Salvia hispanica</i> Extract in Diabetic Rat
Cardiovascular & Hematological Agents in Medicinal Chemistry Depression Associated with Diabetes: From Pathophysiology to Treatment
Current Diabetes Reviews Biologic Therapy and Treatment Options in Diabetic Retinopathy with Diabetic Macular Edema
Current Drug Safety Production of Pancreatic Beta-Cells from Stem Cells
Current Diabetes Reviews Towards Newer Molecular Targets for Chronic Diabetic Complications
Current Vascular Pharmacology Non-pharmacological Strategies Against Systemic Inflammation: Molecular Basis and Clinical Evidence
Current Pharmaceutical Design The Impact of In Vitro Fertilization on the Health of the Mother and the Offspring
Current Women`s Health Reviews Insight on the Pathogenesis of Diabetic Nephropathy from the Study of Podocyte and Mesangial Cell Biology
Current Diabetes Reviews Effects of Vitamin C and E Against Oxidative Stress: Is Antioxidant Supplementation Efficient?
Current Nutraceuticals Food Services Menu Engineering: Preference, Acceptability, and Popularity Index of Local Food Package Menus to Control the Glycemic Responses of T2DM Subjects
Current Nutrition & Food Science The Management of Gestational Diabetes
Current Diabetes Reviews Identification of New Pancreatic Beta Cell Targets for In Vivo Imaging by a Systems Biology Approach
Current Pharmaceutical Design